USPTO serial 79122580
NOVAJECT
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- STRUCK, ROBERT J
- Law office
- TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NOVAJECT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ann Lamport Hammitte
Ann Lamport Hammitte Lando & Anastasi, LLPOne Main Street, 11th FloorCambridge, MA 02142UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Syringes sold filled with TNF (tumor necrosis factor), epinephrine, glucagon, atropine or benzodiazepine; injectors sold filled with TNF (tumor necrosis factor), epinephrine, glucagon, atropine or benzodiazepine; syringes sold filled with interferon, interleukin, triptan, growth factor hormone for the treatment of growth deficiency, clotting factor for the treatment of bleeding disorders or growth factor antagonist for the treatment of acromegaly; injectors sold filled with interferon, interleukin, triptan, growth factor for the treatment of growth deficiency, clotting factor for the treatment of bleeding disorders or growth factor antagonist for the treatment of acromegaly; syringes sold filled with biological drugs for the treatment of immunological disease and cancer; injectors sold filled with biological drugs for the treatment of immunological disease and cancer; injectors sold filled with insulin; pharmaceutical and veterinary preparations | SECTION 70 - CANCELLED | — |
| 010 | Medical fluid injectors; disposable syringes; disposable injectors; hypodermic syringes; hypodermic injectors; injection syringes (syringe barrels); medical syringes; medical injectors; syringes for medical purposes and for injectors; injectors for medical purposes and for injections; autoinjectors for medical purposes and for injections; medical and veterinary apparatus and instruments | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 29, 2023 | UNDN | UNDELIVERABLE MAIL - NO ACTION TAKEN | — |
| Feb 20, 2023 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Feb 19, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 1, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 11, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 2, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 29, 2014 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 12, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 12, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 12, 2013 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 12, 2013 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 15, 2013 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jul 13, 2013 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 3, 2013 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 3, 2013 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 8, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 11, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 11, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 9, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 8, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 8, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 3, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 3, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 27, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |